Academic yr: <<< Previous
2016
2017
2018
|
2019
|
2020
Next >>>
Department of Pharmacology
|
■ Summary
|
■ Research grants & projects
|
1.
|
(Grant No.：18K07245)
Budget amount：\1,400,000 (Principal investigator)
|
|
2.
|
Budget amount：\9,000,000 (Principal investigator)
|
|
3.
|
Budget amount：\2,000,000 (Principal investigator)
|
|
To the top
|
|
■ Research works
| Journal |
Book |
Presentation |
Other presentations |
| Japanese | English |
Japanese | English |
Domestic | international |
| First author | Corresponding
Author | Co-author | First author | Corresponding
Author | Co-author |
First author | Co-author | First author | Co-author |
Presenter | Co-presenter | Presenter | Co-presenter |
Presenter | Co-presenter |
| 1 | 1 | 0 | 4 | 3 | 2 |
0 | 2 | 0 | 0 |
1 | 0 |
1 | 1 |
0 | 0 |
|
|
To the top
|
|
■ Published papers
|
Original article
|
|
1.
|
Tomita Takeshi, Ieguchi Katsuaki, Deguchi Atsuko, Takita Morichika, Tsukahara Fujiko, Hiratsuka Sachie, Maru Yoshiro：
Lung Tumor Cell Recruitment Assay.
Journal of visualized experiments : JoVE
(144)
：e53172
, 2019.2
DOI:10.3791/53172
|
|
2.
|
TAKITA Morichika†, TSUKAHARA Fujiko†, MISHIMA Taishi, IEGUCHI Katsuaki, YAMADA Masayuki, HONDA Hiroaki, MARU Yoshiro*：
Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL.
Oncotarget
9
(60)
：31682-31696
, 2018.8
DOI:10.18632/oncotarget.25849
|
|
3.
|
Tomita Takeshi†*, Ieguchi Katsuaki, Takita Morichika, Tsukahara Fujiko, Yamada Masayuki, Egly Jean-Marc, Maru Yoshiro*：
C1D is not directly involved in the repair of UV-damaged DNA but protects cells from oxidative stress by regulating gene expressions in human cell lines.
Journal of biochemistry
164
(6)
：415-426
, 2018.8
DOI:10.1093/jb/mvy069
|
|
4.
|
Hiratsuka S, Tomita T, Mishima T, Matsunaga Y, Omori T, Ishibashi S, Yamaguchi S, Hosogane T, Watarai H, Omori-Miyake M, Yamamoto T, Shibata N, Watanabe A, Aburatani H, Tomura M, High KA, Maru Y.：
Hepato-entrained B220+CD11c+NK1.1+ cells regulate pre-metastatic niche formation in the lung.
EMBO Molecular Medicine
10
(7)
：pii: e8643
, 2018.7
DOI:10.15252/emmm.201708643
|
|
Review article
|
|
1.
|
Katsuaki Ieguchi†, Yoshiro Maru：
Roles of EphA1/A2 and ephrin-A1 in cancer.
Cancer Science
110
(3)
：841-848
, 2019.3
DOI:10.1111/cas.13942
|
|
2.
|
塚原富士子†, 丸義朗：
悪性腫瘍の最先端（４）分子標的薬.
東京女子医科大学雑誌
88
(6)
：129-137
, 2018.12
DOI:https://doi.org/10.24488/jtwmu.88.6_129
|
|
To the top
|
|
■ Books
|
1.
|
出口敦子, 丸 義朗：
がん転移と自然免疫.
自然免疫の最前線
1271-1275.
医歯薬出版,
東京, 日本,
2018.6
|
|
2.
|
出口 敦子, 丸 義朗：
【自然免疫の最前線】 自然免疫系による疾患の誘導と制御 がん転移と自然免疫.
医学のあゆみ
1271-1275.
医歯薬出版(株),
日本,
2018.6
|
|
To the top
|
|
■ Academic conference presentation
|
1.
|
Maru Yoshiro：
Immuno-thrombotic regulation of pulmonary pre-metastatic niche by liver.
EACR-AACR-ISCR Conference: The Cutting Edge of Contemporary Cancer Research,
Jerusalem, Israel,
2018/10
|
|
2.
|
◎Niida-Kawaguchi M, Tsukahara F, Sudou N, Yamamoto T, Sawada M, Maru Y, Watabe K, Shibata N：
Selective autophagy eliminates ALS-related mutant SOD1 protein in cultured microglia.
19th International Congress of Neuropathology,
Tokyo,Japan,
2018/09
|
|
3.
|
◎塚原富士子：
新しい臨床研究法.
第48回日本腎臓学会東部学術大会,
東京,
2018/10
|
|
To the top
|
|
